Cargando…
Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects
In an earlier single-dose escalation study to evaluate the safety and pharmacokinetics of orally administered des-aspartate-angiotensin I (DAA-I) in healthy subjects, the plasma level of DAA-I could not be determined because DAA-I is rapidly degraded in the circulation. The present study investigate...
Autores principales: | Lee, Kok-Onn, Tian, Edmund Feng, Cai, Martin Hui, Wang, Hong, Chan, Yiong-Huak, Sim, Meng-Kwoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833902/ https://www.ncbi.nlm.nih.gov/pubmed/29168127 http://dx.doi.org/10.1007/s40268-017-0218-4 |
Ejemplares similares
-
A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects
por: Lee, Ko-Onn, et al.
Publicado: (2016) -
Author’s Reply to Srinivas: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects”
por: Sim, Meng-Kwoon, et al.
Publicado: (2016) -
Des-Aspartate-Angiotensin I Attenuates Mortality of Mice Exposed to Gamma Radiation via a Novel Mechanism of Action
por: Wang, Hong, et al.
Publicado: (2015) -
Comment on: “A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects”
por: Srinivas, Nuggehally R.
Publicado: (2016) -
Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat
por: Wangensteen, Rosemary, et al.
Publicado: (2022)